Neuroprotective effects of ıdebenone and citicoline in experimental traumatic optic neuropathy: electrophysiological, histological, and biochemical assessments in a rat model
Documenta Ophthalmologica, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Basım Tarihi: 2026
- Doi Numarası: 10.1007/s10633-026-10156-0
- Dergi Adı: Documenta Ophthalmologica
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest), Pharma Collection (ProQuest)
- Anahtar Kelimeler: Citicoline, Electrophysiology, Glial fibrillary acidic protein, Idebenone, Traumatic optic neuropathy
- Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet
Özet
Objectıve: This study aims to investigate the neuroprotective efficacy of idebenone and citicoline in a rat model of traumatic optic neuropathy (TON), induced by controlled optic nerve (ON) crush injury. Materıals and methods: Forty male Wistar rats (250–300 g) were randomly assigned to four groups (n=10). TON was induced in Groups 1, 2 and 3 via right ON crush. Group 1 received no treatment; Group 2 received idebenone (50 mg/kg/day), and Group 3 received citicoline (1 g/kg/day) via a nasogastric tube, starting 24 h post-injury. Group 4 served as sham controls. Flash and pattern visual evoked potentials (fVEP, pVEP) were recorded at baseline, 48 h, and day 28. The flash and pattern VEP tests were performed using the MonPackONE device. Blood biomarkers (ischemia-modified albumin (IMA), total and native thiol) were analyzed, and histological evaluations included hematoxylin–eosin (H&E) staining and glial fibrillary acidic protein (GFAP) monoclonal antibody immunohistochemistry. Results: At day 2, VEP tests indicated delayed latency and decreased amplitude in Groups 1–3 versus the sham group. By day 28, Groups 2 and 3 showed significant VEP improvement over Group 1. Biochemical analysis demonstrated higher thiol levels in Group 3 compared to Group 2 on day 28; however, this difference was not statistically significant. GFAP staining in the retina and ON tissues was highest in Group 1 and lowest in Group 4. ON thickness was greater in Group 2 than in Group 3, but the difference was also not statistically significant. Conclusıon: Although neither treatment demonstrated superiority over the other, both oral citicoline and idebenone provided neuroprotection in TON, as evidenced by improved electrophysiological function, greater retina ganglion cell survival, and elevated systemic antioxidant markers.